Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
life sciences
liver disease
2
×
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acetylon pharmaceuticals
allergan
ambys medicines
biotech
bristol-myers squibb
cell therapy
clinical data
clinical trials
constellation pharmaceuticals
deals
gene therapy
genentech
genfit
gilead sciences
holger willenbring
intercept pharmaceuticals
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
ldl-c
liver
madrigal pharmaceuticals
mark pruzanski
markus grompe
martin burke
nash
new york
What
liver
2
×
new
aiming
ambys
approved
big
biotech
control
data
deadly
deal
debuted
disease
diseases
drug
fatty
formed
future
horizon
intercept
known
launch
make
marketed
medicine
medicines
nash
nonalcoholic
startup
steatohepatitis
takeda
today
track
treatments
unusual
variety
Language
Current search:
liver
×
photo
×
" liver disease "
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
